Float Short %

5.5

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

-2.5

EPS Last/This Y

6.74

EPS This/Next Y

4.1

Price

3.79

Target Price

12.33

Analyst Recom

1.67

Performance Q

-14.83

Relative Volume

1.49

Beta

1.56

Ticker: AGEN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	AGEN	4.32	0.12	0.00	16275
2025-11-14	AGEN	4.33	0.12	0.00	16312
2025-11-17	AGEN	4.32	0.12	0.01	16270
2025-11-18	AGEN	4.24	0.11	0.08	17694
2025-11-19	AGEN	4.21	0.11	27.00	17682
2025-11-20	AGEN	4.3	0.11	0.25	17670
2025-11-21	AGEN	4.23	0.11	0.31	17643
2025-11-24	AGEN	4.3	0.12	0.16	4853
2025-11-25	AGEN	4.38	0.13	0.04	5561
2025-11-26	AGEN	4.57	0.12	0.01	5638
2025-12-01	AGEN	4.32	0.15	13.43	5906
2025-12-02	AGEN	4.18	0.24	0.14	6397
2025-12-03	AGEN	4.18	0.24	0.00	6456
2025-12-04	AGEN	4.07	0.23	19.25	6594
2025-12-05	AGEN	3.93	0.17	4.00	6280
2025-12-08	AGEN	4.05	0.17	0.30	6293
2025-12-09	AGEN	3.91	0.17	12.38	6270
2025-12-10	AGEN	4.1	0.15	0.00	6146
2025-12-11	AGEN	4.09	0.15	0.55	6159
2025-12-12	AGEN	3.8	0.15	0.12	6144
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	AGEN	4.33	171.3	-46.0	0.80
2025-11-14	AGEN	4.33	70.6	-61.4	-3.85
2025-11-17	AGEN	4.32	70.6	-61.4	-3.85
2025-11-18	AGEN	4.24	70.6	-60.7	-3.85
2025-11-19	AGEN	4.20	70.6	-61.1	-3.85
2025-11-20	AGEN	4.29	70.6	-62.1	-3.85
2025-11-21	AGEN	4.22	70.6	-61.0	-3.85
2025-11-24	AGEN	4.30	70.6	-62.1	-3.85
2025-11-25	AGEN	4.38	70.6	-62.0	-3.85
2025-11-26	AGEN	4.57	70.6	-62.7	-3.85
2025-12-01	AGEN	4.31	70.6	-59.7	-3.85
2025-12-02	AGEN	4.17	70.6	-60.3	-3.85
2025-12-03	AGEN	4.17	70.6	-61.4	-3.85
2025-12-04	AGEN	4.07	70.6	-60.6	-3.85
2025-12-05	AGEN	3.93	70.6	-60.5	-3.85
2025-12-08	AGEN	4.03	70.6	-	-3.85
2025-12-09	AGEN	3.92	70.6	-60.4	-3.85
2025-12-10	AGEN	3.92	70.6	-62.8	-3.85
2025-12-11	AGEN	4.08	70.6	-61.4	-3.85
2025-12-12	AGEN	3.79	70.6	-59.1	-3.85
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	AGEN	0.00	1.49	0
2025-11-14	AGEN	0.00	1.49	5.91
2025-11-17	AGEN	0.00	5.98	5.91
2025-11-18	AGEN	0.00	5.98	5.91
2025-11-19	AGEN	0.00	5.98	5.91
2025-11-20	AGEN	0.00	5.98	5.91
2025-11-21	AGEN	0.00	5.98	5.91
2025-11-24	AGEN	0.00	-0.16	5.91
2025-11-25	AGEN	0.00	-0.16	5.91
2025-11-26	AGEN	0.00	-0.16	5.55
2025-12-01	AGEN	0.00	-0.32	5.55
2025-12-02	AGEN	0.00	-0.32	5.55
2025-12-03	AGEN	0.00	-0.32	5.55
2025-12-04	AGEN	0.00	-0.32	5.55
2025-12-05	AGEN	0.00	-0.32	5.55
2025-12-08	AGEN	0.00	-0.27	5.55
2025-12-09	AGEN	0.00	-0.27	5.55
2025-12-10	AGEN	0.00	-0.27	5.50
2025-12-11	AGEN	0.00	-0.27	5.50
2025-12-12	AGEN	0.00	-0.27	5.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="AGEN" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

1.94

Avg. EPS Est. Current Quarter

-0.6

Avg. EPS Est. Next Quarter

-0.56

Insider Transactions

Institutional Transactions

-0.27

Beta

1.56

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.2

Max Drawdown 5-Year %

-98.8

Target Price

12.33

P/E

Forward P/E

PEG

P/S

1.21

P/B

P/Free Cash Flow

EPS

-2.13

Average EPS Est. Cur. Y

-3.85

EPS Next Y. (Est.)

0.25

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-33.12

Relative Volume

1.49

Return on Equity vs Sector %

-14

Return on Equity vs Industry %

EPS 1 7Days Diff

-4.6

EPS 1 30Days Diff

-4.65

EBIT Estimation

-59.1

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”AGEN” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AGEN” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AGEN” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AGEN” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AGEN” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AGEN” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”AGEN” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Agenus Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 316

Agenus Inc., a clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract t; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

stock quote shares AGEN – Agenus Inc. Stock Price stock today

news today AGEN – Agenus Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch AGEN – Agenus Inc. yahoo finance google finance

stock history AGEN – Agenus Inc. invest stock market

stock prices AGEN premarket after hours

ticker AGEN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AGEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y